Nurix Therapeutics (NRIX) Stock Highlights

22.64 | -0.66%

2024-11-21 03:00:16

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The companys pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.

Statistics

Range Today

21.88 22.88

Volume Today 682.2K

Range 1 Year

5.65 29.56

Volume 1 Year 227.57M

Range 3 Year

4.22 32.19

Volume 3 Year 434.26M

Range 10 Year

4.22 52.38

Volume 10 Year 556.35M

Highlights

Market Capitalization 1.94B (small)

Floating Shares 57.48M

Current Price 22.64

Price To Earnings -9.32

Price To Revenue 26.86

Price To Book 4.87

Earnings Per Share -2.91

Payout Ratio 0%

Performance

Latest -0.66%

1 Month -10.48%

3 Months -2.92%

6 Months +36.47%

1 Year +258.8%

3 Years -29.12%

5 Years +25.36%

10 Years +25.36%

Benchmarks

Market Capitalization

162 / 368

Gross Profits

252 / 278

Total Revenue

107 / 300

Total Rank

210 / 368

Free Cashflow

244 / 352

Performance 5 years

97 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.